← Evidence map

ArticleClinical, cosmetic and investigational dermatology2026

Omalizumab Combined with Cyclosporine for the Treatment and Management of Refractory Urticarial Vasculitis.

Xinlong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41858605